Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Small Cap Fund median (37 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 28 Nov 2025 – 20 Aug 2026, limited by Helios Small Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Helios Small Cap Fund | Nifty Smallcap 250 |
|---|---|---|
| 28 Nov 2025 | ₹100.00 | ₹100.00 |
| 20 Dec 2025 | ₹97.61 | ₹98.06 |
| 11 Jan 2026 | ₹95.02 | ₹96.87 |
| 02 Feb 2026 | ₹91.43 | ₹92.68 |
| 24 Feb 2026 | ₹92.63 | ₹95.22 |
| 18 Mar 2026 | ₹87.95 | ₹90.56 |
| 10 Apr 2026 | ₹92.23 | ₹94.15 |
| 02 May 2026 | ₹98.11 | ₹99.99 |
| 24 May 2026 | ₹101.69 | ₹100.26 |
| 15 Jun 2026 | ₹106.18 | ₹103.35 |
| 07 Jul 2026 | ₹110.16 | ₹107.29 |
| 29 Jul 2026 | ₹110.26 | ₹107.44 |
| 20 Aug 2026 | ₹115.64 | ₹109.60 |
| Metric | Helios · Direct NAV ₹11.61 Very High risk Unrated | Category median Small Cap Fund · 37 funds |
|---|---|---|
| — | +12.86% | |
| — | +18.08% | |
| — | +18.44% | |
| — | +17.52% | |
| +15.64% | +19.96% | |
| +56.12% | — | |
| — | +21.45% | |
| — | +21.03% | |
| — | +19.53% | |
| Risk | ||
| 18.24% | 17.14% | |
| — | 0.69 | |
| — | 0.93 | |
| -16.90% | -32.37% | |
| Nifty Smallcap 250 | — | |
| — | +2.27% | |
| — | 0.86 | |
| — | 88.4% | |
| — | 77.8% | |
| 0.92% | 0.92% | |
| ₹994.19Cr | ₹4,512Cr | |
| 1.00% | — | |
| None | — | |
| ₹2.03K | — | |
| ₹5.00K | — | |
| 13% | 27% | |
| Alok Bahl | — | |
| 28 Nov 2025 | — | |
| 87 | — | |
| 18.9% | — | |
| 1.7% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.